ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 58 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10 | 0.0% | 14,498 | -15.6% | 0.00% | 0.0% |
| Q4 2022 | $10 | -100.0% | 17,174 | -76.8% | 0.00% | -96.0% |
| Q2 2021 | $259,000 | +15.6% | 73,955 | +257.9% | 0.02% | +4.2% |
| Q4 2020 | $224,000 | -33.1% | 20,665 | -36.5% | 0.02% | -57.9% |
| Q3 2020 | $335,000 | -40.4% | 32,527 | +20.8% | 0.06% | -12.3% |
| Q2 2020 | $562,000 | +473.5% | 26,924 | +49.9% | 0.06% | +712.5% |
| Q3 2019 | $98,000 | +48.5% | 17,964 | -13.9% | 0.01% | +100.0% |
| Q4 2018 | $66,000 | -43.6% | 20,862 | +3.7% | 0.00% | -33.3% |
| Q1 2018 | $117,000 | +120.8% | 20,123 | +38.1% | 0.01% | +100.0% |
| Q3 2017 | $53,000 | – | 14,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
| RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
| Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
| WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
| Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
| 683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
| Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
| Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |